[$300M Raised] Mapping the Human Immune System for Drug Discovery: Noam Solomon on Building Immunai

In this latest episode of Sit Down Startup, Adam O'Donnell chats with Noam Solomon, CEO of Immunai, about his incredible journey from academia to building a groundbreaking biotech startup. Hear Noam's fascinating backstory growing up in Israel and his move to the U.S. for a postdoc at MIT and Harvard, and how that paved the way for the creation of Immunai. Learn about the challenges of navigating product-market fit in the deep science space and the responsibility that comes with managing significant funding. Noam also shares insights on the crucial balance between building innovative technology and staying closely connected with customer needs. Tune in for an inspiring conversation on the future of drug discovery and the importance of humility in research and entrepreneurship. 00:01:49: Noam’s Academic Journey and Move to the U.S. 00:08:16: The Weight of Managing Large-Scale Funding 00:16:46: Balancing Innovation and Customer Feedback 00:19:26: Advice for Founders and Navigating Challenges Apply to the Zendesk for Startups program. Qualifying startups can use Zendesk six months for free. Click to learn more:

You can listen to [$300M Raised] Mapping the Human Immune System for Drug Discovery: Noam Solomon on Building Immunai online on Radio and Podcast. Open the player on this page to stream the available audio.

[$300M Raised] Mapping the Human Immune System for Drug Discovery: Noam Solomon on Building Immunai is an episode from Sit Down Startup by Adam O'Donnell.

This episode is 23:45 long.

This episode was published on Aug 28, 2024.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Sit Down Startup when more episodes are available from the podcast feed.